AURA
Price
$6.46
Change
-$0.10 (-1.52%)
Updated
Oct 21 closing price
Capitalization
669.93M
14 days until earnings call
Intraday BUY SELL Signals
ZURA
Price
$4.13
Change
+$0.13 (+3.25%)
Updated
Oct 21 closing price
Capitalization
395.77M
21 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AURA vs ZURA

AURA vs ZURA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
AURA vs. ZURA commentary
Oct 22, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AURA is a Hold and ZURA is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for AURA with price predictions
Oct 21, 2026

AURA's RSI Indicator ascending out of oversold territory

The RSI Oscillator for AURA moved out of oversold territory on September 28, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 21 similar instances when the indicator left oversold territory. In 19 of the 21 cases the stock moved higher. This puts the odds of a move higher at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 59 of 73 cases where AURA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.

The Momentum Indicator moved above the 0 level on October 15, 2026. You may want to consider a long position or call options on AURA as a result. In 86 of 111 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 77%.

The Moving Average Convergence Divergence (MACD) for AURA just turned positive on October 06, 2026. Looking at past instances where AURA's MACD turned positive, the stock continued to rise in 45 of 54 cases over the following month. The odds of a continued upward trend are 83%.

Following a +7.54% 3-day Advance, the price is estimated to grow further. Considering data from situations where AURA advanced for three days, in 215 of 278 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AURA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.

The Aroon Indicator for AURA entered a downward trend on October 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 30 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.125) is normal, around the industry mean (2.988). P/E Ratio (-3.734) is within average values for comparable stocks, (-1.158). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (123.903) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).

The Tickeron PE Growth Rating for this company is 33 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 56 (best 1 - 100 worst), indicating steady price growth. AURA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AURA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for ZURA with price predictions
Oct 21, 2026

ZURA sees its 50-day moving average cross bearishly below its 200-day moving average

The 50-day moving average for ZURA moved below the 200-day moving average on October 02, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 21, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ZURA as a result. In 52 of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 63%.

The 10-day moving average for ZURA crossed bearishly below the 50-day moving average on September 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 80%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ZURA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.

ZURA broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for ZURA entered a downward trend on October 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ZURA's RSI Oscillator exited the oversold zone, 19 of 23 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

The Moving Average Convergence Divergence (MACD) for ZURA just turned positive on October 07, 2026. Looking at past instances where ZURA's MACD turned positive, the stock continued to rise in 41 of 60 cases over the following month. The odds of a continued upward trend are 68%.

Following a +8.40% 3-day Advance, the price is estimated to grow further. Considering data from situations where ZURA advanced for three days, in 152 of 187 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 20 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 29 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.008) is normal, around the industry mean (2.988). P/E Ratio (-3.688) is within average values for comparable stocks, (-1.158). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (123.903) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).

The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating steady price growth. ZURA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ZURA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

TECHNICAL ANALYSIS
Technical Analysis
AURAZURA
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
68%
Momentum
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
63%
MACD
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
68%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
71%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
74%
Advances
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 1 day ago
81%
Declines
ODDS (%)
Bearish Trend 8 days ago
83%
Bearish Trend 3 days ago
82%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
55%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
77%
COMPARISON
Comparison
Oct 22, 2026
Stock price -- (AURA: $6.46 vs. ZURA: $4.13)
Brand notoriety: AURA and ZURA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AURA: 96% vs. ZURA: 125%
Market capitalization -- AURA: $669.93M vs. ZURA: $395.77M
AURA [@Biotechnology] is valued at $669.93M. ZURA’s [@Biotechnology] market capitalization is $395.77M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $132.95B. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AURA’s FA Score shows that 2 FA rating(s) are green while ZURA’s FA Score has 2 green FA rating(s).

  • AURA’s FA Score: 2 green, 3 red.
  • ZURA’s FA Score: 2 green, 3 red.
According to our system of comparison, both AURA and ZURA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AURA’s TA Score shows that 5 TA indicator(s) are bullish while ZURA’s TA Score has 4 bullish TA indicator(s).

  • AURA’s TA Score: 5 bullish, 2 bearish.
  • ZURA’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, AURA is a better buy in the short-term than ZURA.

Price Growth

AURA (@Biotechnology) experienced а +4.70% price change this week, while ZURA (@Biotechnology) price change was -6.35% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.90%. For the same industry, the average monthly price growth was -15.91%, and the average quarterly price growth was -14.30%.

Reported Earning Dates

AURA is expected to report earnings on Nov 05, 2026.

ZURA is expected to report earnings on Nov 12, 2026.

Industries' Descriptions

@Biotechnology (+1.90% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
AURA
Daily Signal:
Gain/Loss:
ZURA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PDSB1.240.28
+29.10%
PDS Biotechnology Corp
MANH235.832.97
+1.28%
Manhattan Associates
TRMK45.29-0.11
-0.24%
Trustmark Corp
AMSS0.33-0.01
-2.79%
AMASS Brands Inc.
NPB15.13-0.65
-4.12%
Northpointe Bancshares Inc

AURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, AURA has been loosely correlated with MGTX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if AURA jumps, then MGTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AURA
1D Price
Change %
AURA100%
-1.52%
MGTX - AURA
45%
Loosely correlated
-1.10%
EDIT - AURA
44%
Loosely correlated
-2.71%
MLTX - AURA
44%
Loosely correlated
+3.20%
CABA - AURA
43%
Loosely correlated
-4.35%
CLDX - AURA
43%
Loosely correlated
-3.04%
More

ZURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZURA has been loosely correlated with VIR. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ZURA jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZURA
1D Price
Change %
ZURA100%
+3.25%
VIR - ZURA
44%
Loosely correlated
-1.58%
RCUS - ZURA
42%
Loosely correlated
-19.58%
TNXP - ZURA
41%
Loosely correlated
-6.06%
FDMT - ZURA
39%
Loosely correlated
-3.66%
AURA - ZURA
39%
Loosely correlated
-1.52%
More